Physician profile
Allyson E Mobley
NPI 1982892196
$2,419.98
in general payments reported to CMS, 2019-2025
18 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $971 · 2022: $400 · 2023: $346 · 2024: $314 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,631.37 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Scilex Pharmaceuticals INC. | $251.56 | 2021-2023 | Ztlido |
| Almatica Pharma LLC | $68.02 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.33 | 2025 | Relistor |
| Virtus Pharmaceuticals LLC | $45.53 | 2021 | |
| Abbott Laboratories | $45.52 | 2021-2022 | |
| Redhill Biopharma INC. | $39.56 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $38.92 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $34.57 | 2021-2024 | Xtampza |
| Abbvie INC. | $32.65 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $30.28 | 2023 | Zilretta, Iovera, Exparel |
| Si-Bone, INC. | $27.46 | 2021 | |
| Biodelivery Sciences International, INC. | $26.09 | 2021 | |
| Convatec INC. | $25.50 | 2024 | |
| Grt US Holding, INC. | $22.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $18.49 | 2021 | |
| Ibsa Pharma INC. | $15.73 | 2023 | Tirosint, Licart |
| Curonix LLC | $13.61 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Mobley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.